SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 107 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $928,000 | +52.4% | 964,096 | +88.4% | 0.00% | – |
Q1 2022 | $609,000 | +102.3% | 511,824 | +454.5% | 0.00% | – |
Q4 2021 | $301,000 | -78.7% | 92,300 | -70.8% | 0.00% | -100.0% |
Q3 2021 | $1,414,000 | -53.5% | 316,375 | -43.3% | 0.00% | -50.0% |
Q2 2021 | $3,040,000 | +140.7% | 557,713 | +230.4% | 0.00% | +100.0% |
Q1 2021 | $1,263,000 | -69.4% | 168,793 | -55.6% | 0.00% | -66.7% |
Q4 2020 | $4,126,000 | +209.1% | 380,266 | +151.8% | 0.00% | +50.0% |
Q3 2020 | $1,335,000 | -18.2% | 151,026 | -1.3% | 0.00% | 0.0% |
Q2 2020 | $1,632,000 | -55.1% | 153,063 | -70.9% | 0.00% | -60.0% |
Q4 2019 | $3,632,000 | +1772.2% | 525,585 | +2699.4% | 0.01% | – |
Q3 2019 | $194,000 | -69.5% | 18,775 | -73.1% | 0.00% | -100.0% |
Q1 2019 | $637,000 | +18.8% | 69,715 | -27.5% | 0.00% | 0.0% |
Q4 2018 | $536,000 | -74.0% | 96,185 | -44.4% | 0.00% | -66.7% |
Q3 2018 | $2,059,000 | -46.3% | 172,846 | -54.0% | 0.00% | -40.0% |
Q2 2018 | $3,834,000 | +80.3% | 375,466 | +129.3% | 0.01% | +66.7% |
Q1 2018 | $2,126,000 | +27.6% | 163,770 | +44.7% | 0.00% | 0.0% |
Q3 2017 | $1,666,000 | +795.7% | 113,206 | +872.1% | 0.00% | – |
Q1 2017 | $186,000 | – | 11,646 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |